Unknown

Dataset Information

0

Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.


ABSTRACT: Pulmonary hypertension is prevalent in adult patients with sickle cell disease and is strongly associated with early mortality and markers of hemolysis, in particular, serum lactate dehydrogenase (LDH). Intravascular hemolysis leads to impaired bioavailability of nitric oxide (NO), mediated by NO scavenging by plasma oxyhemoglobin and by arginine degradation by plasma arginase. We hypothesized that serum LDH may represent a convenient biomarker of intravascular hemolysis and NO bioavailability, characterizing a clinical subphenotype of hemolysis-associated vasculopathy. In a cohort of 213 patients with sickle cell disease, we found statistically significant associations of steady-state LDH with low levels of hemoglobin and haptoglobin and high levels of reticulocytes, bilirubin, plasma hemoglobin, aspartate aminotransferase, arginase, and soluble adhesion molecules. LDH isoenzyme fractionation confirmed predominance of LD1 and LD2, the principal isoforms within erythrocytes. In a subgroup, LDH levels closely correlated with plasma cell-free hemoglobin, accelerated NO consumption by plasma, and impaired vasodilatory responses to an NO donor. Remarkably, this simple biomarker was associated with a clinical subphenotype of pulmonary hypertension, leg ulceration, priapism, and risk of death in patients with sickle cell disease. We propose that LDH elevation identifies patients with a syndrome of hemolysis-associated NO resistance, endothelial dysfunction, and end-organ vasculopathy.

SUBMITTER: Kato GJ 

PROVIDER: S-EPMC1895723 | biostudies-literature | 2006 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.

Kato Gregory J GJ   McGowan Vicki V   Machado Roberto F RF   Little Jane A JA   Taylor James J   Morris Claudia R CR   Nichols James S JS   Wang Xunde X   Poljakovic Mirjana M   Morris Sidney M SM   Gladwin Mark T MT  

Blood 20051115 6


Pulmonary hypertension is prevalent in adult patients with sickle cell disease and is strongly associated with early mortality and markers of hemolysis, in particular, serum lactate dehydrogenase (LDH). Intravascular hemolysis leads to impaired bioavailability of nitric oxide (NO), mediated by NO scavenging by plasma oxyhemoglobin and by arginine degradation by plasma arginase. We hypothesized that serum LDH may represent a convenient biomarker of intravascular hemolysis and NO bioavailability,  ...[more]

Similar Datasets

| S-EPMC8791181 | biostudies-literature
| S-EPMC1976348 | biostudies-literature
| S-EPMC6419954 | biostudies-literature
| S-EPMC2765899 | biostudies-literature
| S-EPMC10561851 | biostudies-literature
2018-03-13 | PXD007713 | Pride
| S-EPMC4046159 | biostudies-literature
| S-EPMC11302077 | biostudies-literature
2017-11-03 | GSE92263 | GEO
| S-EPMC9820196 | biostudies-literature